American Institute for Advanced Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420K Sell
350
-40
-10% -$40.9K 0.24% 106
2026
Q1
$359K Sell
390
-10
-3% -$10.1K 0.23% 109
2025
Q4
$430K Hold
400
0.28% 90
2025
Q3
$305K Hold
400
0.2% 114
2025
Q2
$312K Hold
400
0.22% 107
2025
Q1
$330K Hold
400
0.25% 99
2024
Q4
$309K Hold
400
0.23% 105
2024
Q3
$354K Hold
400
0.25% 99
2024
Q2
$362K Hold
400
0.28% 91
2024
Q1
$311K Hold
400
0.25% 100
2023
Q4
$233K Hold
400
0.21% 107
2023
Q3
$215K Buy
+400
New +$206K 0.2% 112

Other funds holding LLY

American Institute for Advanced Investment Management's LLY Position: Q2 2026 in Review

American Institute for Advanced Investment Management reduced its Eli Lilly (LLY) stake by 10% in Q2 2026, selling an estimated $40.9K and leaving 350 shares worth $420K. The position accounts for 0.24% of the portfolio, ranked #106.

American Institute for Advanced Investment Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $430K in Q4 2025. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • American Institute for Advanced Investment Management held 350 shares of Eli Lilly worth $420K as of Q2 2026.
  • American Institute for Advanced Investment Management sold 40 Eli Lilly shares in Q2 2026, an estimated $40.9K.
  • Eli Lilly made up 0.24% of American Institute for Advanced Investment Management's portfolio in Q2 2026, its #106 holding.
  • American Institute for Advanced Investment Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • American Institute for Advanced Investment Management's Eli Lilly position peaked at $430K in Q4 2025.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on American Institute for Advanced Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.